1. Home
  2. TIL vs EFSI Comparison

TIL vs EFSI Comparison

Compare TIL & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • EFSI
  • Stock Information
  • Founded
  • TIL 2018
  • EFSI 1881
  • Country
  • TIL United States
  • EFSI United States
  • Employees
  • TIL N/A
  • EFSI N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • EFSI Major Banks
  • Sector
  • TIL Health Care
  • EFSI Finance
  • Exchange
  • TIL Nasdaq
  • EFSI Nasdaq
  • Market Cap
  • TIL 171.7M
  • EFSI 176.7M
  • IPO Year
  • TIL 2021
  • EFSI N/A
  • Fundamental
  • Price
  • TIL $17.21
  • EFSI $32.55
  • Analyst Decision
  • TIL Buy
  • EFSI Strong Buy
  • Analyst Count
  • TIL 5
  • EFSI 2
  • Target Price
  • TIL $114.00
  • EFSI $40.00
  • AVG Volume (30 Days)
  • TIL 85.6K
  • EFSI 48.4K
  • Earning Date
  • TIL 03-04-2025
  • EFSI 01-01-0001
  • Dividend Yield
  • TIL N/A
  • EFSI 3.79%
  • EPS Growth
  • TIL N/A
  • EFSI 62.68
  • EPS
  • TIL N/A
  • EFSI 4.32
  • Revenue
  • TIL N/A
  • EFSI $70,233,000.00
  • Revenue This Year
  • TIL N/A
  • EFSI $26.68
  • Revenue Next Year
  • TIL N/A
  • EFSI N/A
  • P/E Ratio
  • TIL N/A
  • EFSI $7.59
  • Revenue Growth
  • TIL N/A
  • EFSI 11.27
  • 52 Week Low
  • TIL $9.62
  • EFSI $27.02
  • 52 Week High
  • TIL $92.00
  • EFSI $36.93
  • Technical
  • Relative Strength Index (RSI)
  • TIL 42.69
  • EFSI N/A
  • Support Level
  • TIL $17.87
  • EFSI N/A
  • Resistance Level
  • TIL $19.61
  • EFSI N/A
  • Average True Range (ATR)
  • TIL 1.68
  • EFSI 0.00
  • MACD
  • TIL -0.06
  • EFSI 0.00
  • Stochastic Oscillator
  • TIL 5.69
  • EFSI 0.00

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About EFSI Eagle Financial Services Inc Common Stock

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending, and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

Share on Social Networks: